A study published in Engineering has identified fucosylated immunoglobulin G (IgG) as a key mediator contributing to adipose ...

Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, ...

A newly identified receptor could redefine how scientists treat bone loss by directly restoring the balance between bone ...

Uveitis, which accounts for 10%–15% of blindness cases in developed nations and 25% in developing regions, represents a ...

Researchers at Ben-Gurion University of the Negev have identified a protein that plays a central role in enabling aggressive ...

A study published in Engineering has identified fucosylated immunoglobulin G (IgG) as a key mediator contributing to adipose tissue dysfunction during ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the independent Data ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

New study uncovers triplex-mediated transcriptional activation driving tumor suppression in HCC Hepatocellular carcinoma (HCC ...

The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...

Leucine-rich repeat-containing 8A (LRRC8A) is a ubiquitously expressed transmembrane protein that functions as the essential ...